We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.52B
AUM Growth
+$1.2B
Cap. Flow
+$726M
Cap. Flow %
9.65%
Top 10 Hldgs %
19.11%
Holding
866
New
79
Increased
318
Reduced
279
Closed
56

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$75M
2
BIIB icon
Biogen
BIIB
+$70.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$60.1M
4
MRK icon
Merck
MRK
+$54.6M
5
GILD icon
Gilead Sciences
GILD
+$33.1M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$19.1M
2
IRBT
iRobot
IRBT
+$15.5M
3
DGX icon
Quest Diagnostics
DGX
+$15.4M
4
CL icon
Colgate-Palmolive
CL
+$14.8M
5
PM icon
Philip Morris
PM
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33.26%
2 Technology 16.05%
3 Financials 11.26%
4 Consumer Discretionary 7.98%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BXP icon
501
Boston Properties
BXP
$11B
$1.88M 0.03%
15,295
-188
-1% -$23.9K
PBA icon
502
Pembina Pipeline
PBA
$29B
$1.88M 0.03%
55,309
-607
-1% -$21.1K
WY icon
503
Weyerhaeuser
WY
$17.2B
$1.87M 0.02%
58,031
-176,820
-75% -$6.14M
SLF icon
504
Sun Life Financial
SLF
$46B
$1.86M 0.02%
46,803
-3,712
-7% -$149K
AZO icon
505
AutoZone
AZO
$50.2B
$1.85M 0.02%
2,383
RCI icon
506
Rogers Communications
RCI
$17.7B
$1.85M 0.02%
35,968
+382
+1% +$19.5K
LITS
507
Lite Strategy Inc
LITS
$33.2M
$1.83M 0.02%
+21,250
New +$1.74M
PAYX icon
508
Paychex
PAYX
$41.1B
$1.83M 0.02%
24,842
MGM icon
509
MGM Resorts International
MGM
$11.8B
$1.78M 0.02%
63,954
-1,095
-2% -$31.7K
HIG icon
510
Hartford Financial Services
HIG
$38.4B
$1.78M 0.02%
35,708
JD icon
511
JD.com
JD
$41.8B
$1.78M 0.02%
68,100
-4,500
-6% -$147K
CAH icon
512
Cardinal Health
CAH
$53.7B
$1.77M 0.02%
32,872
-58,332
-64% -$2.99M
EVRG icon
513
Evergy
EVRG
$19.8B
$1.76M 0.02%
32,091
-96,118
-75% -$5.44M
DM
514
DELISTED
Dominion Energy Midstream Ptr LP
DM
$1.75M 0.02%
+98,005
New +$1.57M
KSU
515
DELISTED
Kansas City Southern
KSU
$1.75M 0.02%
15,466
+3,022
+24% +$344K
CLX icon
516
Clorox
CLX
$11.8B
$1.74M 0.02%
11,549
+630
+6% +$89.5K
ACGN
517
DELISTED
Aceragen Inc
ACGN
$1.74M 0.02%
+11,482
New +$1.64M
MRVL icon
518
Marvell Technology
MRVL
$170B
$1.74M 0.02%
89,938
-127,057
-59% -$2.61M
STLD icon
519
Steel Dynamics
STLD
$36.1B
$1.73M 0.02%
38,284
+2,260
+6% +$104K
DAL icon
520
Delta Air Lines
DAL
$57B
$1.72M 0.02%
29,715
+492
+2% +$27.1K
LEG icon
521
Leggett & Platt
LEG
$1.5B
$1.72M 0.02%
39,183
GEN icon
522
Gen Digital
GEN
$16.1B
$1.7M 0.02%
79,862
-493,372
-86% -$10M
FE icon
523
FirstEnergy
FE
$28.5B
$1.69M 0.02%
45,400
VNO icon
524
Vornado Realty Trust
VNO
$7.43B
$1.67M 0.02%
22,827
-8,838
-28% -$655K
EGRX
525
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.66M 0.02%
24,000

Similar funds

Candriam SCA's Q3 2018 Portfolio in Review

As of Q3 2018, Candriam SCA held 866 positions worth $7.52B, up 19% from $6.32B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA deployed $726M of net new capital in Q3 2018, opening 79 new positions and adding to 318 existing holdings. Its largest new stake was Varonis Systems: 541,092 shares worth $13.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.1M trimmed.

  • Candriam SCA's largest Q3 2018 buy was Varonis Systems: 541,092 shares worth $13.2M.
  • Candriam SCA added most to Amgen in Q3 2018, an estimated $75M increase.
  • Candriam SCA's biggest Q3 2018 reduction was Advanced Micro Devices, cutting an estimated $19.1M.
  • Candriam SCA fully exited iRobot in Q3 2018, selling an estimated $15.5M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.52B portfolio in Q3 2018.
  • Candriam SCA opened 79 new positions and closed 56 in Q3 2018.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $7.52B.

Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.